Neuroendovascular Coil Market – Global Industry Insights, Trends, Opportunity Analysis, 2021-2027 the new research from Coherent Market Insights has announced report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The Neuroendovascular Coil Market offers a summary of product specification, production analysis, technology, product type, considering key features such as gross margin, revenue & cost. Neuroendovascular Coil Market report provides key statistics on the Market status of the Neuroendovascular Coil manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1707
The neuroendovascular coil is a device that is commonly used to treat aneurysms. An aneurysm is a condition in which the wall of an artery weakens, causing an unnatural protrusion. Unruptured aneurysms and ruptured aneurysms are the two forms of aneurysms that can be treated using a neuroendovascular coil. Unruptured aneurysms do not rupture and grow large or strain on the brain or nerves, whereas ruptured aneurysms leak blood into the subarachnoid space around the brain. When a neuroendovascular coil is inserted into an artery, blood flow into the aneurysm is stopped. This causes the blood within the aneurysm to coagulate, causing the aneurysm to burst.
Neuroendovascular Coil Market Drivers
The introduction of new neuroendovascular coils into the market is projected to be a major driver of global neuroendovascular coil market growth. Three Rivers Medical, Inc., for example, acquired CE certification for their latest Rio Embolization Coil System in 2017. Endovascular embolization of intracranial aneurysms and other neurovascular anomalies such as arteriovenous fistulae and arteriovenous malformations is possible with the Rio Embolization Coil System. Cerenovus, a Johnson & Johnson company, released the Galaxy G3 tiny coil in January 2018, a next-generation embolic coil that can be utilised for endovascular treatment of cerebral infarction aneurysms and hemorrhagic stroke. The US Food and Drug Administration granted Cerenovus 510(k) clearance for the Galaxy G3 micro coil in 2017. (FDA). At the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Meeting in 2017, Medtronic Plc. unveiled their latest Concerto 3-D Detachable Coil System. Strategic mergers and acquisitions by key competitors in the neuroendovascular coil market are also expected to drive the global neuroendovascular coil market’s growth. For example, in 2015, Medtronic Plc. acquired Medina Medical for US$ 150 million to widen its product portfolio with Medina Medical’s neuroendovascular coil. Furthermore, the increasing prevalence of brain aneurysms is again expected to increase the demand for neuroendovascular coils for its treatment. For example, according to the data published by Brain Aneurysms Foundation in 2017, around 6 million people or one in every 50 people in the U.S. are suffering from brain aneurysm and around 30,000 people in the U.S suffers from brain aneurysm annually.
Neuroendovascular Coil Market Restraint
The introduction of alternatives to neuroendovascular coils such as stents, liquid agents, and flow diversion devices is likely to slow the growth of the worldwide neuroendovascular coil market. For example, in 2017, Stryker Corporation received the U.S. Food and Drug Administration approval for its latest Neuroform Atlas Stent System for the treatment of wide neck aneurysms.
Neuroendovascular Coil Market Regional Analysis
Because of the presence of significant companies in the area and their rapid product introductions, North America is likely to have a dominating position in the global neuroendovascular coil market over the forecast period. For example, Medtronic Plc., Stryker Corporation, and Johnson and Johnson are the U.S.-based key players and in 2015, Codman Neuro, which is a part of DePuy Synthes Companies of Johnson & Johnson, launched a latest platform of embolic coils indicated for the treatment of brain aneurysms. Moreover, Asia Pacific is expected to show a significant growth in the near future due to increasing approval of novel neuroendovascular coils in the region. For instance, in 2012, Penumbra, Inc. received Shonin approval by the Japanese Ministry of Health, Labor, and Welfare for its new Penumbra Coil 400. Penumbra Coil 400 is a novel endovascular coiling technology indicated for the treatment of intracranial aneurysms. Such approvals are expected to drive growth of the neuroendovascular coil market in Asia Pacific.
Neuroendovascular Coil Market Key Players
Medtronic Plc., Three Rivers Medical, Inc., Stryker Corporation, Johnson & Johnson, Cardinal Health Inc., Penumbra, Inc., Boston Scientific Corporation, Cook Medical Inc., and Terumo Corporation are the leading participants in the neuroendovascular coil market. The market’s major players are concentrating on launching new items on a regular basis.. For instance, in 2013, Terumo Interventional Systems launched its new Detachable Azur CX Peripheral Coil System at the 11th Vascular InterVentional Advances Conference (VIVA).
Neuroendovascular Coil Market Taxonomy:
The global neuroendovascular coil market is segmented on the basis of product type, indication, end user, and region.
By Product Type-
- Guglielmi Detachable Coils (GDC)
- Matrix Coils
- Biopolymer Coated
- Hydrogel Coated
- Ruptured aneurysms
- Unruptured aneurysms
By End User-
- Ambulatory Surgery Center
- North America
- Latin America
- Asia Pacific
- Middle East
Buy This Complete Business Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/1707
Major Players Are: Stryker, Codman (DePuy), MicroVention, Medtronic Plc., Penumbra Inc., Cardinal Health, Johnson & Johnson, Boston Scientific, Cook Medical Inc., Terumo Corporation, Braile Biomedica, Kaneka Corporation, and Balt USA LLC.
Main points in Neuroendovascular Coil Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Neuroendovascular Coil Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Neuroendovascular Coil Industry Impact
Chapter 2 Neuroendovascular Coil Competition by Types, Applications, and Top Regions and Countries
2.1 Neuroendovascular Coil (Volume and Value) by Type
2.3 Neuroendovascular Coil (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Neuroendovascular Coil Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Neuroendovascular Coil Market Analysis
Chapter 6 East Asia Neuroendovascular Coil Market Analysis
Chapter 7 Europe Neuroendovascular Coil Market Analysis
Chapter 8 South Asia Neuroendovascular Coil Market Analysis
Chapter 9 Southeast Asia Neuroendovascular Coil Market Analysis
Chapter 10 Middle East Neuroendovascular Coil Market Analysis
Chapter 11 Africa Neuroendovascular Coil Market Analysis
Chapter 12 Oceania Neuroendovascular Coil Market Analysis
Chapter 13 South America Neuroendovascular Coil Market Analysis
Chapter 14 Company Profiles and Key Figures in Neuroendovascular Coil Business
Chapter 15 Neuroendovascular Coil Market Forecast (2021-2027)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027